Literature DB >> 15988579

Diabetic cardiomyopathy in uncomplicated type 2 diabetes is associated with the metabolic syndrome and systemic inflammation.

M Diamant, H J Lamb, J W A Smit, A de Roos, R J Heine.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15988579     DOI： 10.1007/s00125-005-1821-4

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  8 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

Review 2.  Adaptation and maladaptation of the heart in diabetes: Part I: general concepts.

Authors:  Heinrich Taegtmeyer; Patrick McNulty; Martin E Young
Journal:  Circulation       Date:  2002-04-09       Impact factor: 29.690

Review 3.  Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors.

Authors:  A Nicoletti; J B Michel
Journal:  Cardiovasc Res       Date:  1999-03       Impact factor: 10.787

4.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  A Festa; R D'Agostino; G Howard; L Mykkänen; R P Tracy; S M Haffner
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

5.  Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus.

Authors:  Michaela Diamant; Hildo J Lamb; Ymte Groeneveld; Edwin L Endert; Jan W A Smit; Jeroen J Bax; Johannes A Romijn; Albert de Roos; Jasper K Radder
Journal:  J Am Coll Cardiol       Date:  2003-07-16       Impact factor: 24.094

Review 6.  Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease?

Authors:  D S Bell
Journal:  Diabetes Care       Date:  1995-05       Impact factor: 19.112

7.  Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance.

Authors:  Patricia Iozzo; Panithaya Chareonthaitawee; David Dutka; D John Betteridge; Ele Ferrannini; Paolo G Camici
Journal:  Diabetes       Date:  2002-10       Impact factor: 9.461

8.  Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study.

Authors:  Ramachandran S Vasan; Lisa M Sullivan; Ronenn Roubenoff; Charles A Dinarello; Tamara Harris; Emelia J Benjamin; Douglas B Sawyer; Daniel Levy; Peter W F Wilson; Ralph B D'Agostino
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690
  8 in total
  18 in total

1.  Upregulation of eNOS and unchanged energy metabolism in increased susceptibility of the aging type 2 diabetic GK rat heart to ischemic injury.

Authors:  Martine Desrois; Kieran Clarke; Carole Lan; Christiane Dalmasso; Mark Cole; Bernard Portha; Patrick J Cozzone; Monique Bernard
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-08-20       Impact factor: 4.733

2.  Myocardial lysyl oxidase regulation of cardiac remodeling in a murine model of diet-induced metabolic syndrome.

Authors:  Sherma Zibadi; Randy Vazquez; Derek Moore; Douglas F Larson; Ronald R Watson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-10       Impact factor: 4.733

Review 3.  Molecular mechanisms of diabetic cardiomyopathy.

Authors:  Heiko Bugger; E Dale Abel
Journal:  Diabetologia       Date:  2014-01-30       Impact factor: 10.122

4.  High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes.

Authors:  L J M Boonman-de Winter; F H Rutten; M J M Cramer; M J Landman; A H Liem; G E H M Rutten; A W Hoes
Journal:  Diabetologia       Date:  2012-05-18       Impact factor: 10.122

5.  Irisin inhibits high glucose-induced endothelial-to-mesenchymal transition and exerts a dose-dependent bidirectional effect on diabetic cardiomyopathy.

Authors:  Xue Liu; Haroon Mujahid; Bing Rong; Qing-Hua Lu; Wei Zhang; Peng Li; Na Li; Er-Shun Liang; Qi Wang; Dong-Qi Tang; Nai-Lin Li; Xiao-Ping Ji; Yu-Guo Chen; Yu-Xia Zhao; Ming-Xiang Zhang
Journal:  J Cell Mol Med       Date:  2017-10-23       Impact factor: 5.310

Review 6.  The Role of Toll-Like Receptor Signaling in the Progression of Heart Failure.

Authors:  Lili Yu; Zhiwei Feng
Journal:  Mediators Inflamm       Date:  2018-02-08       Impact factor: 4.711

Review 7.  Molecular Mechanisms Responsible for Diastolic Dysfunction in Diabetes Mellitus Patients.

Authors:  Jovana Nikolajević Starčević; Miodrag Janić; Mišo Šabovič
Journal:  Int J Mol Sci       Date:  2019-03-09       Impact factor: 5.923

Review 8.  Molecular Mechanisms of Retinoid Receptors in Diabetes-Induced Cardiac Remodeling.

Authors:  Jing Pan; Rakeshwar S Guleria; Sen Zhu; Kenneth M Baker
Journal:  J Clin Med       Date:  2014-06-04       Impact factor: 4.241

9.  HDAC Inhibition Modulates Cardiac PPARs and Fatty Acid Metabolism in Diabetic Cardiomyopathy.

Authors:  Ting-I Lee; Yu-Hsun Kao; Wen-Chin Tsai; Cheng-Chih Chung; Yao-Chang Chen; Yi-Jen Chen
Journal:  PPAR Res       Date:  2016-06-30       Impact factor: 4.964

Review 10.  Curcumin, A Polyphenolic Curcuminoid With Its Protective Effects and Molecular Mechanisms in Diabetes and Diabetic Cardiomyopathy.

Authors:  Jia Zheng; Jing Cheng; Sheng Zheng; Qianyun Feng; Xinhua Xiao
Journal:  Front Pharmacol       Date:  2018-05-09       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.